Literature DB >> 10526548

Methadone maintenance and state Medicaid managed care programs.

D McCarty1, R G Frank, G C Denmead.   

Abstract

Coverage for methadone services in state Medicaid plans may facilitate access to the most effective therapy for heroin dependence. State Medicaid plans were reviewed to assess coverage for methadone services, methadone benefits in managed care, and limitations on methadone treatment. Medicaid does not cover methadone maintenance medication in 25 states (59 percent). Only 12 states (24 percent) include methadone services in Medicaid managed care plans. Moreover, two of the 12 states limit coverage for counseling or medication and others permit health plans to set limits. State authorities for Medicaid and substance abuse can collaborate to ensure that appropriate medication and treatment services are available for Medicaid recipients who are dependent on opioids and to construct payment mechanisms that minimize incentives that discourage enrollment among heroin-dependent individuals.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10526548      PMCID: PMC2751129          DOI: 10.1111/1468-0009.00139

Source DB:  PubMed          Journal:  Milbank Q        ISSN: 0887-378X            Impact factor:   4.911


  13 in total

1.  Mental health, drug use, and the transition from welfare to work.

Authors:  Isaac D Montoya; David C Bell; John S Atkinson; Carl W Nagy; Donna D Whitsett
Journal:  J Behav Health Serv Res       Date:  2002-05       Impact factor: 1.505

2.  Access to publicly funded methadone maintenance treatment in two western states.

Authors:  Dennis Deck; Matthew J Carlson
Journal:  J Behav Health Serv Res       Date:  2004 Apr-Jun       Impact factor: 1.505

3.  Public managed care and service access in outpatient substance abuse treatment units.

Authors:  Emmeline Chuang; Rebecca Wells; Jeffrey A Alexander
Journal:  J Behav Health Serv Res       Date:  2011-10       Impact factor: 1.505

4.  Medicaid coverage and access to publicly funded opiate treatment.

Authors:  Dennis D Deck; Wyndy L Wiitala; Katherine E Laws
Journal:  J Behav Health Serv Res       Date:  2006-07       Impact factor: 1.505

5.  Substance abuse treatment organizations as mediators of social policy: slowing the adoption of a congressionally approved medication.

Authors:  Stanley S Wallack; Cindy Parks Thomas; Timothy C Martin; Jon Chilingerian; Sharon Reif
Journal:  J Behav Health Serv Res       Date:  2008-07-31       Impact factor: 1.505

6.  Methadone maintenance and the cost and utilization of health care among individuals dependent on opioids in a commercial health plan.

Authors:  Dennis McCarty; Nancy A Perrin; Carla A Green; Michael R Polen; Michael C Leo; Frances Lynch
Journal:  Drug Alcohol Depend       Date:  2010-10-01       Impact factor: 4.492

Review 7.  Bridging the gap: a hybrid model to link efficacy and effectiveness research in substance abuse treatment.

Authors:  Kathleen M Carroll; Bruce J Rounsaville
Journal:  Psychiatr Serv       Date:  2003-03       Impact factor: 3.084

8.  Medicaid coverage, methadone maintenance, and felony arrests: outcomes of opiate treatment in two states.

Authors:  Dennis Deck; Wyndy Wiitala; Bentson McFarland; Kevin Campbell; John Mullooly; Antoinette Krupski; Dennis McCarty
Journal:  J Addict Dis       Date:  2009

9.  Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.

Authors:  Rachel M Burns; Rosalie L Pacula; Sebastian Bauhoff; Adam J Gordon; Hollie Hendrikson; Douglas L Leslie; Bradley D Stein
Journal:  Subst Abus       Date:  2015-11-13       Impact factor: 3.716

10.  Influence of ownership on access in outpatient substance abuse treatment.

Authors:  Tammie A Nahra; Jeffrey Alexander; Harold Pollack
Journal:  J Subst Abuse Treat       Date:  2009-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.